Canopy Growth Corporation is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Smith Falls, ON. Its filings are on EDGAR under CIK 1737927; the figures the desk reads are not on file yet.
Product businessMedicinal Chemicals & Botanical ProductsSmith Falls, ONfilings since 20188 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2833, Medicinal Chemicals & Botanical Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 2.6 out of ten, 8 of 9 metrics filed and 1 estimated: past 1.1 out of ten, present 2.5 out of ten, future 4.4 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 0.8 out of ten. 8 warning events since 2018; the latest 2026-08-07. 8th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 1.8 out of ten. +17.6% a year over 9 filed years; profitable in 0 of 10. 18th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 0.3 out of ten. CrossAssetData estimate 0.3/10, confidence 35 of 100 (one part). 3rd percentile among 18 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Financial health (present): 3.3 out of ten. ROE -38%: lost 38¢ per shareholder dollar. Leverage 38%: owes 38¢ per asset dollar. 33rd percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 1.7 out of ten. bottom 17% of 18 in its family; net margin -92.4%. 17th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 2.0 out of ten. bottom 20% of 12 in its family for leadership; chief executive since 2025. 20th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 3.3 out of ten. bottom 33% of 18 in its family for room to expand. 33rd percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 3.4 out of ten. bottom 34% of 18 in its family for growth drivers. 34th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 7.9 out of ten. top 21% of 18 in its family for expectations against reality. 79th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-06-15 for the period ended 2026-03-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-07 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-07 (on EDGAR). Newest filing: Form DEFA14A, 2026-10-06. Filings on record since 2018. Read from EDGAR 2026-10-12.
Where the revenue comes from
Lines of business in fiscal 2026: Cannabis 75%, Storz and Bickel 25%. By geography: Canada 65%, Germany 22%, United States 10%, Other Geographical Area 3%. As tagged in its annual report (Form 10-K, filed 2026-06-15).
Who runs it
Mongeau, Luc (Chief Executive Officer); Stewart, Thomas Carlton (Chief Financial Officer and Chief Accounting Officer); Lazzarato, David Angelo (Chief Accounting Officer); Gedeon, Christelle (Chief Legal Officer and Corporate Secretary); Atkins, M Shan (director); Bayern, Joseph (director); Yanofsky, Theresa (director); Kruh, Willy (director). 8 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.